These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5906 related articles for article (PubMed ID: 3594487)

  • 1. Lysosome rich cells contain the lytic activity of lymphokine-activated killer cell populations.
    Agah R; Shau H; Mazumder A
    Cancer Immunol Immunother; 1987; 24(3):247-52. PubMed ID: 3594487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the relationship of human natural killer and lymphokine-activated killer cells with lysosomal staining and analysis of surface marker phenotypes.
    Shau H; Gray D; Mitchell MS
    Cell Immunol; 1988 Aug; 115(1):13-23. PubMed ID: 2456860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of lymphokine-activated killer cell activity from non-NK precursor cells.
    Ramsdell FJ; Lindemann RA; Shau HY; Gray JD; Golub SH
    Cell Immunol; 1988 Oct; 116(2):287-98. PubMed ID: 3180226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and selection of human lymphokine activated killer cell effectors and novel recycling intermediates by unique light-scattering properties.
    Loudon WG; Abraham SR; Owen-Schaub LB; Hemingway LL; Hemstreet GP; DeBault LE
    Cancer Res; 1988 Apr; 48(8):2184-92. PubMed ID: 3258186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human oncogene-transfected tumor cells display differential susceptibility to lysis by lymphokine-activated killer cells (LAK) and natural killer cells.
    Lanza LA; Wilson DJ; Ikejiri B; Roth JA; Grimm EA
    J Immunol; 1986 Oct; 137(8):2716-20. PubMed ID: 3489774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similarities between LAK cells derived from human thymocytes and peripheral blood lymphocytes: expression of the NKH-1 and CD3 antigens.
    Ramsdell FJ; Gray JD; Golub SH
    Cell Immunol; 1988 Jun; 114(1):209-21. PubMed ID: 2967111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of lymphokine-activated killer cells: characterization of effector cells mediating prophylaxis.
    Bukowski JF; Yang H; Welsh RM
    J Virol; 1988 Oct; 62(10):3642-8. PubMed ID: 2458485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The heterogeneity of target recognition by lymphokine-activated killer precursor cells.
    Ibayashi Y; Gray JD; Golub SH; Daibo M; Yamaki T; Kawahara T; Kubota T; Hashi K
    Jpn J Cancer Res; 1990 Sep; 81(9):927-35. PubMed ID: 2121694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural characteristics of lymphokine-activated killer cells of the rat in comparison with natural killer cells.
    Kaneda K; Nagamuta M; Kataoka M; Yamamoto H; Kishiye T; Wake K
    Arch Histol Cytol; 1991 May; 54(2):119-32. PubMed ID: 1873071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of different tumor cells to lysis by lymphokine activated killer cells can be mediated by distinct mechanisms.
    Bean P; Mazumder A
    Immunobiology; 1992 Jun; 185(1):63-77. PubMed ID: 1398742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and purification of NK cells with lysosomotropic vital stains: correlation of lysosome content with NK activity.
    Shau H; Dawson JR
    J Immunol; 1985 Jul; 135(1):137-40. PubMed ID: 2582030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and characterization of cytotoxic granules from human lymphokine (interleukin 2) activated killer cells.
    Lowrey DM; Hameed A; Lichtenheld M; Podack ER
    Cancer Res; 1988 Aug; 48(16):4681-8. PubMed ID: 3260817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
    Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
    J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 296.